VA
APGE icon

VR Adviser’s Apogee Therapeutics APGE Stock Holding History

VR Adviser’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$715M Hold
8,493,321
– – 26.68% 1
2025
Q4 		$641M Hold
8,493,321
– – 31.67% 1
2025
Q3 		$337M Hold
8,493,321
– – 18.99% 1
2025
Q2 		$369M Hold
8,493,321
– – 27.64% 1
2025
Q1 		$317M Hold
8,493,321
– – 27% 1
2024
Q4 		$385M Hold
8,493,321
– – 26.4% 1
2024
Q3 		$499M Hold
8,493,321
– – 26.13% 1
2024
Q2 		$334M Hold
8,493,321
– – 21.28% 1
2024
Q1 		$564M Hold
8,493,321
– – 26.85% 1
2023
Q4 		$237M Hold
8,493,321
– – 16.28% 2
2023
Q3 		$181M Buy
+8,493,321
New +$187M 19.04% 1

Other funds holding APGE

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return